Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Revenue

    Back to Income Statement
PIRAMAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹9,151 Cr₹8,171 Cr₹7,082 Cr₹6,559 Cr₹6,315 Cr

What is the latest Revenue of PIRAMAL PHARMA ?

The latest Revenue ratio of PIRAMAL PHARMA is ₹9,151 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹9,151 Cr
Mar2024₹8,171 Cr
Mar2023₹7,082 Cr
Mar2022₹6,559 Cr
Mar2021₹6,315 Cr

How is Revenue of PIRAMAL PHARMA Trending?

Years Revenue % Change
Mar2025 ₹9,151 Cr
11.99
Mar2024 ₹8,171 Cr
15.39
Mar2023 ₹7,082 Cr
7.97
Mar2022 ₹6,559 Cr
3.87
Mar2021 ₹6,315 Cr -

Compare Revenue of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹20,456.4 Cr 4.4% 7.5% -32% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,497.0 Cr -1.4% -6.2% -1.6% Stock Analytics
DIVIS LABORATORIES ₹166,939.0 Cr -0.1% 2.3% 9.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,109.0 Cr -1.8% -4.9% 28.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,578.0 Cr -0.4% -6% 5.3% Stock Analytics
CIPLA ₹99,761.1 Cr 0.4% -2.6% -17.6% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

4.4%

7.5%

-32%

SENSEX

0.5%

3.2%

2.3%


You may also like the below Video Courses